Malaria Treatment Market Scope And Analysis

Malaria Treatment Market Report Scope

Competitive Landscape and Key Companies:

A few of the prominent players operating in the global malaria treatment market are Cipla Ltd, Sun Pharmaceutical Industries Ltd, Sanofi SA, GSK Plc, Novartis AG, Pfizer Inc, Emmaus Life Sciences Inc, AdvaCare Pharma USA LLC, VLP Therapeutics LLC, Lupin Ltd, and Teva Pharmaceutical Industries Ltd. These companies focus on the development of new technologies, advancements in existing products, and expansion of geographic footprint to meet the growing consumer demand worldwide and expand their product range in specialty portfolios. Companies operating in the global malaria treatment market are implementing various inorganic and organic strategies. A few of them are mentioned below:

• In November 2022, Novartis and Medicines for Malaria Venture (MMV) announced its decision to move to a Phase 3 study for a novel non-artemisinin combination to treat uncomplicated malaria. This novel combination also contains an optimized formulation of lumefantrine, which allows it to be given once daily instead of the usual twice-daily administration.
• In October 2021, GlaxoSmithKline (GSK) plc welcomed WHO recommendation for the broader deployment of GSK’s RTS,S malaria vaccine to reduce childhood illness and deaths from malaria in children (living in sub-Saharan Africa and other regions with moderate to high transmission). RTS,S is the first and only malaria vaccine to have been shown in pivotal long-term clinical trials to significantly reduce malaria in children. The vaccine is the result of over 30 years of research led by GSK, with PATH and other partners.